UPDATED Apr 25, 2024
Potentially undervalued companies with a strong past performance and robust balance sheet.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$399.04 | -1.3% | 30.9% | US$3.0t | US$471.24 | PE35.9x | E12.6% | 0.8% | Software | ||
GOOGL | US$156.00 | -0.006% | 45.0% | US$2.0t | US$166.83 | PE26.3x | E11.9% | n/a | Media | ||
AMZN | US$173.67 | -3.1% | 58.1% | US$1.8t | US$210.59 | PE59.4x | E21.6% | n/a | Retail | ||
META | US$441.38 | -12.0% | 85.0% | US$1.3t | US$524.32 | PE24.5x | E12.2% | 0.5% | Media | ||
2330 | NT$766.00 | -4.7% | 55.2% | NT$19.9t | NT$912.98 | PE23.2x | E16.1% | 1.8% | Semiconductors | ||
NOVO B | kr.866.80 | 0.5% | 55.2% | kr.3.9t | kr.904.20 | PE46.2x | E14.7% | 1.1% | Pharmaceuticals & Biotech | ||
CRM | US$273.14 | 0.4% | 39.4% | US$267.9b | US$336.10 | PE64.1x | E18.7% | 0.6% | Software | ||
ADBE | US$473.44 | 0.05% | 27.5% | US$212.1b | US$617.38 | PE44.2x | E17.1% | n/a | Software | ||
NOVN | CHF89.12 | 5.4% | -2.4% | CHF181.8b | CHF98.84 | PE21.9x | E10.0% | 3.7% | Pharmaceuticals & Biotech | ||
ROG | CHF222.20 | 1.0% | -19.6% | CHF179.0b | CHF279.39 | PE15.4x | E8.6% | 4.3% | Pharmaceuticals & Biotech | ||
AXP | US$237.10 | 9.0% | 49.6% | US$172.0b | US$223.21 | PE19.2x | E7.5% | 1.2% | Diversified Financials | ||
PDD | US$125.79 | 10.6% | 90.2% | US$169.5b | US$179.67 | PE20.2x | E23.0% | n/a | Retail | ||
AIR | €158.52 | -1.3% | 26.3% | €124.8b | €175.38 | PE32.9x | E17.6% | 1.1% | Capital Goods | ||
VRTX | US$397.70 | 1.1% | 17.2% | US$102.8b | US$460.34 | PE28.4x | E11.5% | n/a | Pharmaceuticals & Biotech | ||
SAF | €207.50 | -0.3% | 48.1% | €85.8b | €206.26 | PE24.9x | E5.8% | 1.1% | Capital Goods | ||
CSL | AU$278.45 | 2.6% | -8.4% | AU$134.6b | AU$306.71 | PE35.4x | E14.7% | 1.3% | Pharmaceuticals & Biotech | ||
1299 | HK$51.55 | 7.7% | -39.5% | HK$577.2b | HK$94.96 | PE19.6x | E17.9% | 3.1% | Insurance | ||
CRWD | US$298.02 | 1.3% | 136.4% | US$72.0b | US$390.62 | PE806.9x | E34.6% | n/a | Software | ||
SLB | US$49.44 | -2.9% | 3.1% | US$70.2b | US$67.11 | PE16.3x | E13.1% | 2.2% | Energy | ||
NTES | US$94.12 | 1.8% | 6.3% | US$60.7b | US$132.85 | PE14.9x | E7.9% | 2.7% | Media | ||
BBRI | Rp5,150.00 | -5.9% | 0% | Rp787.9t | Rp6,656.54 | PB2.5x | E11.1% | 6.2% | Banks | ||
2454 | NT$981.00 | -6.6% | 48.2% | NT$1.6t | NT$1,199.29 | PE20.3x | E14.0% | 6.2% | Semiconductors | ||
300760 | CN¥285.10 | 4.7% | -7.7% | CN¥344.8b | CN¥396.59 | PE30.4x | E15.0% | 3.0% | Healthcare | ||
600809 | CN¥245.58 | 1.3% | 0.6% | CN¥299.6b | CN¥290.03 | PE28.8x | E16.7% | 1.4% | Food, Beverage & Tobacco |